Life sciences
Real estate requirements for life sciences companies are technically complex, capital intense and atypical for real estate service providers whose principal focus is office or warehouse space.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.
Connect with my local Life Sciences advisor
Life Sciences key contacts
Carl Potter
-
- Principal & Managing Director, Birmingham
-
- Sales & Leasing
- Office Midlands


Life sciences news and updates
-
News Release
South East office activity dominated by flight to quality and appetite for ESG-led stockMay 11, 2022
-
News Release
Q1 2022 office investment up 25% against 10-year average, while occupier take-up slows following active last quarterMay 11, 2022
-
Avison Young marks 11 consecutive years as one of Canada’s Best Managed CompaniesMay 10, 2022
-
News Release
Avison Young recruits Harriet De Freitas in London Markets growth driveMay 9, 2022